|
Dec 5
|
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock
|
|
Sep 7
|
Halozyme Therapeutics (HALO) Down 3.8% Since Last Earnings Report: Can It Rebound?
|
|
Sep 7
|
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
|
|
Aug 9
|
Halozyme (HALO) Q2 Earnings & Revenues Beat, 2023 View Raised
|
|
Aug 9
|
Compared to Estimates, Halozyme Therapeutics (HALO) Q2 Earnings: A Look at Key Metrics
|
|
Aug 8
|
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Top Estimates
|
|
Aug 8
|
HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS
|
|
Aug 8
|
15 Worst Performing Biotech Stocks in 2023
|